ClinicalTrials.gov
public full text
Public Domain
Alternate Day Buprenorphine Administration, Phase X - 15
The purpose of this study is to determine how subjects will make changes in the amount of medication received when given a monetary alternative to buprenorphine.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Alternate-Day Buprenorphine Administration. Phase VII - 8#1229630
- Alternate Day Buprenorphine Administration, Phase XI - 16#969323
- Buprenorphine Dose Alteration Study - 1#1323661
- Alternate Day Buprenorphine Administration, Phase IX - 14#1173846
- Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction#1307694
Record · ID 1337880
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive